Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 40

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 40
---
2018 Incentive Award Plan
     
    S-1/A

    7/09/2018

    10.4

    10.5#
     
    Form of restricted stock unit agreement under Crinetics Pharmaceuticals, Inc. 2018 Incentive Award Plan
     
    10-K

    3/30/2022

    10.5

    10.6#
     
    Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan and offering document thereunder 
     
    S-1/A

    7/09/2018

    10.5

    10.7#
     
    Amended and Restated Employment Agreement, effective as of May 25, 2018, by and between R. Scott Struthers and the Registrant  
     
    S-1

    6/22/2018

    10.6

    10.8#
     
    Amended and Restated Employment Agreement, effective as of May 22, 2018, by and between Marc J.S. Wilson and the Registrant
     
    S-1

    6/22/2018

    10.7

    10.9#
      
    Employment Agreement, effective as of June 15, 2018, by and between Alan Krasner, M.D. and the Registrant 
      
    S-1/A

    7/09/2018

    10.8

    10.10#
      
    Form of Indemnification Agreement for Directors and Officers
      
    S-1/A

    7/09/2018

    10.9

    10.11
      
    Lease Agreement, dated as of February 21, 2018, by and between 6262 Lusk Investors LLC and the Registrant, as amended 
      
    S-1

    6/22/2018

    10.9

    10.12†
     
    Lease Agreement, dated as of September 9, 2022, by and between San Diego 1 LLC and the Registrant
     
    10-Q

    11/14/2022

    10.1

    10.13
     
    First Amendment to Lease, dated December 8, 2023, to the Lease Agreement,